(Q28577013)

31 January 2017

title

Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats (English)

1 reference

31 January 2017

Yoshio Yamamoto

1

1 reference

31 January 2017

Takashi Ono

2

1 reference

31 January 2017

Dipok Kumar Dhar

3

1 reference

31 January 2017

Akira Yamanoi

4

1 reference

31 January 2017

Mitsuo Tachibana

5

1 reference

31 January 2017

Tsuneo Tanaka

6

1 reference

31 January 2017

Naofumi Nagasue

7

1 reference

31 January 2017

publication date

1 June 2008

1 reference

Journal of Gastroenterology and Hepatology

31 January 2017

published in

1 reference

31 January 2017

volume

23

1 reference

31 January 2017

issue

6

1 reference

31 January 2017

page(s)

930–937

1 reference

Troglitazone induces expression of PPARgamma in liver

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2008.05370.X

Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2008.05370.X

Blunted DNA synthesis and delayed S-phase entry following inhibition of Cdk2 activity in the regenerating rat liver

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2008.05370.X

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Medical significance of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-Delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Regulation of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05370.X

10.1111/J.1440-1746.2008.05370.X

21 January 2018

Identifiers

DOI

1 reference

31 January 2017

1 reference